Cargando…

Chronic kidney disease as a cardiovascular risk factor: lessons from kidney donors

Chronic kidney disease (CKD) is a major risk factor for cardiovascular disease but is often associated with other risks such as diabetes and hypertension and can be both a cause and an effect of cardiovascular disease. Although epidemiologic data of an independent association of reduced glomerular f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Price, Anna M., Edwards, Nicola C., Hayer, Manvir K., Moody, William E., Steeds, Richard P., Ferro, Charles J., Townend, Jonathan N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026388/ https://www.ncbi.nlm.nih.gov/pubmed/29792262 http://dx.doi.org/10.1016/j.jash.2018.04.010

Ejemplares similares

Myocardial characterization in pre-dialysis chronic kidney disease: a study of prevalence, patterns and outcomes
por: Price, Anna M., et al.
Publicado: (2019)

Diffuse Myocardial Interstitial Fibrosis and Dysfunction in Early Chronic Kidney Disease
por: Hayer, Manvir Kaur, et al.
Publicado: (2018)

Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors at 5 Years
por: Price, Anna M., et al.
Publicado: (2021)

Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors
por: Moody, William E., et al.
Publicado: (2016)

Early effects of kidney transplantation on the heart - A cardiac magnetic resonance multi-parametric study()
por: Hayer, Manvir K., et al.
Publicado: (2019)

Impaired circumferential and longitudinal myocardial deformation in early stage chronic kidney disease: the earliest features of uremic cardiomyopathy
por: Edwards, Nicola C, et al.
Publicado: (2013)

Premature coronary artery disease and early stage chronic kidney disease
por: Price, A M, et al.
Publicado: (2018)

Early stage chronic kidney disease: a paradigm for diffuse fibrosis and clinical progression
por: Edwards, Nicola C, et al.
Publicado: (2014)

Aortic Calcification and Femoral Bone Density Are Independently Associated with Left Ventricular Mass in Patients with Chronic Kidney Disease
por: Chue, Colin D., et al.
Publicado: (2012)

Coronary flow velocity reserve and inflammatory markers in living kidney donors
por: Radhakrishnan, Ashwin, et al.
Publicado: (2020)

A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
por: Hayer, Manvir K., et al.
Publicado: (2017)

Cytomegalovirus Seropositivity Is Associated with Increased Arterial Stiffness in Patients with Chronic Kidney Disease
por: Wall, Nadezhda A., et al.
Publicado: (2013)

Reference ranges for three-dimensional feature tracking cardiac magnetic resonance: comparison with two-dimensional methodology and relevance of age and gender
por: Liu, Boyang, et al.
Publicado: (2017)

Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?
por: Ferro, Charles J, et al.
Publicado: (2021)

Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease
por: Arnold, Julia J, et al.
Publicado: (2015)

Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trial
por: Chue, Colin D, et al.
Publicado: (2011)

Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial
por: Ng, Khai P, et al.
Publicado: (2016)

Endothelial Nitric Oxide Synthase Single Nucleotide Polymorphism and Left Ventricular Function in Early Chronic Kidney Disease
por: Chand, Sourabh, et al.
Publicado: (2015)

Screening for occult coronary artery disease in potential kidney transplant recipients: time for reappraisal?
por: Ferro, Charles J, et al.
Publicado: (2021)

Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations
por: Law, Jonathan P., et al.
Publicado: (2022)

Coronary microvascular dysfunction: a key step in the development of uraemic cardiomyopathy?
por: Radhakrishnan, Ashwin, et al.
Publicado: (2019)

Comparison of magnetic resonance feature tracking for longitudinal strain calculation with spatial modulation of magnetization imaging analysis
por: Moody, William E, et al.
Publicado: (2013)

Normative annual changes in left ventricular volumes, mass and function among healthy adults: a prospective cardiac magnetic resonance imaging study
por: Moody, William E, et al.
Publicado: (2014)

Prognostic Utility of Calcium Scoring as an Adjunct to Stress Myocardial Perfusion Scintigraphy in End-Stage Renal Disease
por: Moody, William E., et al.
Publicado: (2016)

Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease
por: Tain, You-Lin, et al.
Publicado: (2022)

Changes in left ventricular structure and function associated with renal transplantation: a systematic review and meta‐analysis
por: Pickup, Luke C., et al.
Publicado: (2021)

Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial
por: Ng, Khai P, et al.
Publicado: (2014)

Reference ranges and reproducibility studies for right heart myocardial deformation by feature tracking cardiovascular magnetic resonance imaging()
por: Liu, Boyang, et al.
Publicado: (2017)

Normal values for myocardial deformation within the right heart measured by feature-tracking cardiovascular magnetic resonance imaging()
por: Liu, Boyang, et al.
Publicado: (2018)

Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: Rationale and design of the EARNEST study()
por: Moody, William E., et al.
Publicado: (2014)

Cardiovascular disease in kidney donors: matched cohort study
por: Garg, Amit X, et al.
Publicado: (2012)

Modulation of stroke risk in chronic kidney disease
por: Arnold, Julia, et al.
Publicado: (2016)

Optimum management of asymptomatic moderate-severe degenerative mitral regurgitation: a role for T1 mapping in risk stratification?
por: Edwards, Nicola C, et al.
Publicado: (2014)

Relinquishing Anonymity in Living Donor Kidney Transplantation: Lessons Learned From the UK Policy for Anonymous Donors
por: Pronk, Mathilde C., et al.
Publicado: (2022)

Cardiovascular Complications of Chronic Kidney Disease: An Introduction
por: Warrens, Hilary, et al.
Publicado: (2022)

Bacterial metabolites and cardiovascular risk in children with chronic kidney disease
por: Schlender, Julia, et al.
Publicado: (2021)

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
por: Currie, Gemma, et al.
Publicado: (2016)

Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease
por: Radhakrishnan, Ashwin, et al.
Publicado: (2021)

10. Cardiovascular Risk in Chronic Kidney Disease
por: Lainščak, Mitja
Publicado: (2009)

Evaluation of Kidney Donor Risk Index/Kidney Donor Profile Index as Predictor Tools of Deceased-Donor Kidney Transplant Outcomes in a Greek Cohort
por: Darema, Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o65kl7fastve2675mo0kgq08od